Search hospitals
>
Hawaii
>
Honolulu
Cancer Research Center of Hawaii
Claim this profile
Honolulu, Hawaii 96813
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Leukemia
421 reported clinical trials
17 medical researchers
Summary
Cancer Research Center of Hawaii is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Leukemia and other specialties. Cancer Research Center of Hawaii is involved with conducting 421 clinical trials across 428 conditions. There are 17 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Jami A. Fukui, and Michael Carney, MD.
Area of expertise
Breast Cancer
Cancer Research Center of Hawaii has run 87 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Cancer Research Center of Hawaii has run 68 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Jeffrey L. Berenberg
Straub Clinic and Hospital
2 years of reported clinical research
Jared D. Acoba
Queen's Medical Center
3 years of reported clinical research
Jami A. Fukui
Kapiolani Medical Center for Women and Children
6 years of reported clinical research
Michael Carney, MD
Kapiolani Medical Center for Women and Children
6 years of reported clinical research
Clinical Trials running at Cancer Research Center of Hawaii
Lung Cancer
Breast Cancer
Cancer
Breast cancer
Ovarian Cancer
Esophageal cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Laryngeal Cancer
Prostate Cancer
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting
2 awards
Phase 3
8 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cancer Research Center of Hawaii?
Cancer Research Center of Hawaii is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Leukemia and other specialties. Cancer Research Center of Hawaii is involved with conducting 421 clinical trials across 428 conditions. There are 17 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Jami A. Fukui, and Michael Carney, MD.
Where is Cancer Research Center of Hawaii located?
The Cancer Research Center of Hawaii is situated at the University of Hawaii Cancer Center in Honolulu, HI, on the University of Hawaii at Manoa campus. It is located near the intersection of East-West Road and University Avenue.
Who should I call to ask about financial aid or insurance network?
For cancer patients in Hawaii seeking financial assistance and insurance support, the following resources are available: - **Hawaii Society of Clinical Oncology (HSCO) and Association of Community Cancer Centers (ACCC):** Offers a digital Patient Assistance & Reimbursement Guide with information on financial assistance programs, including direct links, phone numbers, and eligibility criteria. - **American Cancer Society in Hawaii:** Provides free programs, services, and emotional support for managing cancer treatment and recovery. Contact at 1-800-227-2345 for patient services and information. - **The Queen's Health System:** Offers financial resources, health insurance coverage options, and a Billing Portal on MyChart for secure online payments. - **Hawaii Children's Cancer Foundation:** Provides financial assistance for families with a child diagnosed with cancer. Contact at 808-528-5161 for more information and eligibility requirements. - **Hawaii Cancer Care:** Offers financial assistance for cancer patients, with details available on their website.
What insurance does Cancer Research Center of Hawaii accept?
The Cancer Center of Hawaii, part of The Queen's Medical Center, accepts various insurance plans for cancer care services. For detailed information on accepted insurance plans, contact the Cancer Center of Hawaii directly. City of Hope hospitals and Outpatient Care Centers in Hawaii accept commercial insurance, Medicare, Medicaid, and some U.S. Department of Veterans Affairs and TRICARE plans.
What awards or recognition has Cancer Research Center of Hawaii received?
The Cancer Research Center of Hawaii, located in Honolulu, has been awarded a $6 million Cancer Center Support Grant for its research efforts. It holds a national designation that aids in securing approximately $40 million yearly in grants from the National Institutes of Health. The center's Multiethnic Cohort (MEC) study, funded by the National Cancer Institute since 1993, plays a crucial role in exploring cancer disparities across various ethnic groups.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.